• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Drug Information on Twitter


Follow Us on Twitter Twitter

FDA has added the social media site Twitter Exit Disclaimer to its communication and outreach program. Messages on Twitter provide consumers, healthcare professionals, the pharmaceutical industry, and others with timely information on new drug approvals, safety alerts, compliance actions, and consumer information.

Available Twitter Feeds

  • FDA_Drug_Info Exit Disclaimer - Helpful links, information, and news related to up to date drug and regulatory information.


We are not able to respond to replies or direct messages. Please do not reply to tweets with any private, personal, or proprietary information. Send questions, comments to: druginfo@fda.hhs.gov or call 1-888-INFO-FDA

More E-mail Alerts, News feeds, and Podcasts on Drug Topics


Website Policies

Privacy statement; third-party websites


Contact FDA

Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information

Division of Drug Information (CDER)

Office of Communications

Feedback Form

10001 New Hampshire Avenue

Hillandale Building, 4th Floor

Silver Spring, MD 20993